Back to top

ZBIO: Morgan Stanley Raises Price Target, Maintains Overweight Rating | ZBIO Stock News

ZBIO: Morgan Stanley Raises Price Target, Maintains Overweight Rating | ZBIO Stock News

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Zenas BioPharma, Inc. (ZBIO)